Judith Klein-Seetharaman
From Wikipedia, the free encyclopedia
Judith Klein-Seetharaman | |
|---|---|
| Born | May 30, 1971[1] |
| Alma mater | University of Cologne Massachusetts Institute of Technology |
| Scientific career | |
| Institutions | Carnegie Mellon Colorado School of Mines Arizona State University University of Warwick University of Pittsburgh |
| Thesis | Visual signal transduction : studies of light-induced conformational changes in the cytoplasmic face of rhodopsin. (2000) |
Judith Klein-Seetharaman (born May 30, 1971) is a German-American biochemist who is a professor at Arizona State University. Her research considers the structure-function properties of proteins using computational bio-linguistics. She was supported by the Bill & Melinda Gates Foundation to identify novel therapies to tackle HIV.
Klein-Seetharaman was born in Germany. She completed her undergraduate training at the University of Cologne, where she earned dual honours in biology and chemistry.[2][3] After earning her doctorate, she moved to the United States, where she worked in the laboratory of Har Gobind Khorana at the Massachusetts Institute of Technology.[1][2] Her research considered conformational changes in rhodopsin, the G protein coupled receptor.[4] She was a postdoctoral researcher at MIT with Harald Schwalbe, focusing on nuclear magnetic resonance spectroscopy. After eight months as a postdoc, Klein-Seetharaman moved Carnegie Mellon University where she worked with Raj Reddy in biology. She was eventually appointed to the faculty at Carnegie Mellon.[1][5]
